Kamada (KMDA) Dividends Paid - Common (2025 - 2026)
Kamada (KMDA) posted quarterly Dividends Paid - Common of $14.4 million for Q1 2026, up 25.03% year-on-year from $11.5 million in Q1 2025, and up 225.03% on a QoQ basis from -$11.5 million in Q2 2025.
Kamada (KMDA) Dividends Paid - Common (2025 - 2026) Analysis & Trends
Kamada (KMDA) has reported Dividends Paid - Common for 2 consecutive years, with $14.4 million the latest figure, recorded in Q1 2026.
- Quarterly Dividends Paid - Common rose 25.03% year-over-year to $14.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 million (changed N/A YoY) and the FY2025 annual result came in at -$11.5 million, changed N/A from the prior year.
- Dividends Paid - Common grew to $14.4 million in Q1 2026 per KMDA's latest filing, from -$11.5 million in the prior quarter.
- Over the last five years, Dividends Paid - Common for KMDA reached as high as $14.4 million in Q1 2026 and fell as low as -$11.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 224.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.92 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 139.60 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | 14.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.42 Mn |
| Mar 31, 2026 | 14.42 Mn |
| Jun 30, 2025 | -11.53 Mn |
| Jun 30, 2025 | -11.53 Mn |
| Mar 31, 2025 | 11.53 Mn |
| Mar 31, 2025 | 11.53 Mn |